Roche Holding AG
RHHVF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.03 | -0.37 | 0.19 | -0.28 |
| FCF Yield | 2.62% | 4.36% | 3.10% | 2.74% |
| EV / EBITDA | 17.79 | 43.76 | 21.04 | 24.87 |
| Quality | ||||
| ROIC | 11.44% | 3.84% | 9.82% | 7.83% |
| Gross Margin | 75.67% | 72.15% | 75.71% | 69.26% |
| Cash Conversion Ratio | 0.96 | 4.16 | 1.26 | 1.81 |
| Growth | ||||
| Revenue 3-Year CAGR | 1.11% | 0.25% | -0.18% | 0.17% |
| Free Cash Flow Growth | -39.07% | 43.70% | 18.33% | -6.81% |
| Safety | ||||
| Net Debt / EBITDA | 1.95 | 5.51 | 2.86 | 2.92 |
| Interest Coverage | 20.87 | 3.10 | 0.00 | 9.51 |
| Efficiency | ||||
| Inventory Turnover | 1.02 | 1.16 | 0.94 | 1.07 |
| Cash Conversion Cycle | 69.51 | 75.44 | 83.21 | 85.07 |